Clinical Trial Update: Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating stellate ganglion block for long COVID symptoms is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec | Conditions: Long COVID | NA | Status: RECRUITING